SCHEMBL17429655

SCHEMBL17429655

COc1cc(C)c(Br)c(COc2ccccc2C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.43
ABCB1 P08183 7/20 0.42
TP53 P04637 1/20 0.39
HTR1A P08908 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
DRD2 P14416 2/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
RXRG P48443 1/20 0.38
MAPT P10636 2/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2291408 0.84 SCN8A (0.40) ALDH1A1KMT2AMAPTTSHRSMN1; SMN2
SCHEMBL17385899 0.82 VDR (0.51) ALDH1A1KMT2AMAPTTSHRSMN1; SMN2
SCHEMBL8241510 0.76 ABCB1 (0.61) ABCB1HTR1ADRD2L3MBTL1RXRA
SCHEMBL13144446 0.74 ABCB1 (0.60) RECQLABCB1HTR1AADRA1DADRA1A
SCHEMBL22138645 0.73 CDK4 (0.53) RECQLHTR1ANPC1RAB9AALDH1A1
SCHEMBL2292785 0.73 ALDH1A1 (0.57) NPC1RAB9AALDH1A1RXRARXRB
SCHEMBL30342568 0.73 ALDH1A1 (0.57) NPC1RAB9AALDH1A1RXRARXRB
SCHEMBL2289174 0.72 ALDH1A1 (0.39) ALDH1A1MAPT
SCHEMBL13618126 0.72 ABCB1 (0.52) ABCB1HTR1ADRD2L3MBTL1ADRA1D
SCHEMBL3521430 0.71 CDK4 (0.60) HTR1ANPC1RAB9AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF GPR65, GPR119, GPR35 RECQL 4751/4885ABCB1 966/4885TP53 2136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.